Polystyrene anion exchange polymer pharmaceutical composition

Details Polystyrene anion exchange polymer pharmaceutical composition Polystyrene anion exchange polymer pharmaceutical composition

1990-06-12

1993-07-27

Page, Thurman K.

Drug, bio-affecting and body treating compositions

Solid synthetic organic polymer as designated organic active...

Ion exchange resin

521 31, 521 32, A61K 3174

Patent

active

052308855

ABSTRACT:
Polystyrene polymers having a quaternised ammonium group and their use in a method of treatment of hypercholesterolaemia. A particular compound of the invention is (N,N-dimethyl-N-dodecyl-ammoniomethylstyrene-ethyl methacrylate-divinylbenzene co-polymer, chloride salt.

REFERENCES:
patent: 3780171 (1973-12-01), Irmscher et al.
patent: 3898088 (1975-08-01), Cohen et al.
patent: 4198395 (1980-04-01), De Simone
patent: 4311799 (1982-01-01), Miyake et al.
patent: 4510128 (1985-04-01), Khanna
patent: 4532128 (1985-07-01), Sheldon et al.
Walfish, et al., Water, Air & Soil Pollution 12:477-484 (1979).
Carpov, et al., J. Macromol. Sci. Chem., A22(5-7):907.929 (1985).
Takeuchi, et al., Chem. Pharm. Bull. 32(3):823-831 (1984).
Petrariu, et al., Revue Roumaine de Chimie, 25:145-154 (1980).
Wessling, et al., Makromol. Chem., suppl. 10/11:319-336 (1985).

Affiliated with

Also associated with

Rating

Polystyrene anion exchange polymer pharmaceutical composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polystyrene anion exchange polymer pharmaceutical composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polystyrene anion exchange polymer pharmaceutical composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2340972